Rebel ' s Edge -Analyzing Market News- $M, $DKS, $FULC, and Jalen Carter

Join Jon and Pete Najarian on today's episode of Rebel's Edge as they discuss stocks including Fulcrum Therapeutics getting FDA clearance for phase one of their sickle cell disease treatment trials, Dick's dealing with inventory shrink, Macy's reporting reduced sales, and Fabrinet riding the AI…#joinjon #petenajarian #rebeledge #fulcrumtherapeutics #fda #macy #jalencarter #universityofmichigan #jimharbaugh #learn
Source: Reuters: Health - Category: Consumer Health News Source Type: news